ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.28 beats by $0.15
2023-03-16 07:10:40 ET
- Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q4 GAAP EPS of -$0.28 beats by $0.15 .
- The Company ended the year, with cash totaling $9.1 million compared to $13.0 million as of December 31, 2021.
For further details see:
Acurx Pharmaceuticals GAAP EPS of -$0.28 beats by $0.15